lactic acid has been researched along with curcumin in 124 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 11 (8.87) | 29.6817 |
2010's | 103 (83.06) | 24.3611 |
2020's | 10 (8.06) | 2.80 |
Authors | Studies |
---|---|
Brouse, CF; Eberhart, RC; Greilich, PE; Nguyen, KT; Schwade, ND; Sheng, A; Su, SH; Tang, L; Wawro, D | 1 |
Eberhart, RC; Greilich, PE; Nguyen, KT; Satasiya, P; Su, SH; Tang, L | 1 |
Huang, N; Pan, ChJ; Tang, JJ; Wang, J; Weng, YJ | 1 |
Huang, N; Pan, CJ; Shao, ZY; Tang, JJ; Wang, J | 2 |
Hou, SX; Liu, HL; Zhang, JF | 1 |
Bernkop-Schnürch, A; Grabovac, V | 1 |
Huang, N; Pan, C; Ren, L; Tang, J; Wang, J | 2 |
Ankola, DD; Beniwal, V; Kumar, MN; Shaikh, J; Singh, D | 1 |
Aggarwal, BB; Anand, P; Kunnumakkara, AB; Nair, HB; Sung, B; Tekmal, RR; Yadav, VR | 1 |
Mukerjee, A; Vishwanatha, JK | 1 |
Caplan, MJ; Caputo, C; Cartiera, MS; Egan, ME; Ferreira, EC; Saltzman, WM | 1 |
Blum, A; Freeman, D; Ma, L; Panyam, J; Shahani, K; Swaminathan, SK | 1 |
Chauhan, SC; Gupta, BK; Jaggi, M; Yallapu, MM | 1 |
El-Sherbiny, IM; Selvam, P; Smyth, HD | 1 |
Feng, R; Gao, Y; Guo, C; Li, L; Song, Z; Sun, M; Zhai, G | 1 |
Gryczynski, Z; Ranjan, AP; Raut, SL; Thamake, SI; Vishwanatha, JK | 2 |
Aqil, F; Bansal, SS; Goel, M; Gupta, RC; Vadhanam, MV | 1 |
Panyam, J; Shahani, K | 1 |
Acharya, S; Sahoo, SK | 1 |
Chien, CF; Lin, LC; Tsai, TH; Tsai, YM | 1 |
Andrade E Silva, ML; Cunha, WR; Luz, PP; Magalhães, LG; Pereira, AC; Rodrigues, V | 1 |
Guo, M; Tao, Q; Wang, H; Wang, Y; Xie, X; Yu, S; Zhang, F; Zhou, Q; Zou, Y | 1 |
Chauhan, SC; Dobberpuhl, MR; Jaggi, M; Maher, DM; Yallapu, MM | 1 |
Nagarajan, S; Reddy, BS; Tsibouklis, J | 1 |
Chauhan, N; Chauhan, SC; Ebeling, MC; Jaggi, M; Yallapu, MM | 1 |
El-Sherbiny, IM; Smyth, HD | 1 |
Devadasu, VR; Ravi Kumar, MN; Wadsworth, RM | 1 |
Anto, RJ; Deepa, G; Kumar, GS; Nair, KL; Thulasidasan, AK | 1 |
Fukuda, T; Hasumura, T; Kumar, DS; Maekawa, T; Mathew, A; Morimoto, H; Nagaoka, Y; Venugopal, K; Yoshida, Y | 1 |
Arseneault, M; Dao, L; Doggui, S; Ramassamy, C; Sahni, JK | 1 |
Das, M; Sahoo, SK | 1 |
Ampasavate, C; Limtrakul, P; Pitchakarn, P; Punfa, W; Yodkeeree, S | 1 |
Chang-Liao, WL; Chien, CF; Lin, LC; Tsai, TH; Tsai, YM | 1 |
Helson, L; Mukerjee, A; Ranjan, AP; Vishwanatha, JK | 1 |
Chen, LC; da Silva Coelho, L; de Souza, DC; Guillo, LA; Vieira, IL | 1 |
Bonetti, P; Colombo, M; Pandolfi, L; Prosperi, D; Verderio, P | 1 |
Chen, H; Chen, J; Gao, X; Hu, Q; Huang, M; Jiang, X; Qi, H; Qiu, Y; Song, Q; Wang, X; Yao, L | 1 |
Bisoffi, M; Dorsey, J; Garcia-Smith, R; Griffith, JK; Trujillo, KA; Vaughan, RA | 1 |
Kalaivanan, R; Kannan, K; Kesavan, M; Sankar, P; Sarkar, SN; Suresh, S; Telang, AG | 1 |
Chereddy, KK; Coco, R; des Rieux, A; Memvanga, PB; Préat, V; Ucakar, B; Vandermeulen, G | 1 |
Balakrishna, N; Grama, CN; Kumar, MN; Patil, MA; Raghu, G; Reddy, GB; Suryanarayana, P | 1 |
Hu, X; Liu, Y; Shen, H; Szymusiak, M; Wang, ZJ | 1 |
Fu, T; Gu, J; Guo, Y; Jin, H; Lai, Y; Wang, L; Wang, X; Wang, Y; Yao, Q; Ye, X | 1 |
Moustaid-Moussa, N; Nie, S; Su, R; Sun, M; Wang, S; Wu, D; Zhang, J | 1 |
Balasubramanian, S; Girija, AR; Iwai, S; Kizhikkilot, V; Maekawa, T; Nagaoka, Y; Nair, SD; Suzuki, M; Yoshida, Y | 1 |
Duan, W; Li, L; Li, Q; Lin, J; Liu, K; Shigdar, S; Xiang, D; Yang, W | 1 |
Dua, B; Farazuddin, M; Joshi, B; Khan, AA; Owais, M; Zia, Q | 1 |
Korrapati, P; Lakra, R; Sampath, M; Sengottuvelan, B | 1 |
Guo, S; Huang, S; Li, M; Lv, L; Shen, Y; Xu, X | 1 |
Aras, A; Farooqi, AA; Hechenleitner, AA; Khokhar, AR; Pineda, EA; Qureshi, MZ; Silva, MF; Sobczak-Kupiec, A | 1 |
Colombo, M; Corsi, F; Gramatica, F; Marinozzi, MR; Mazzucchelli, S; Morasso, C; Pandolfi, L; Prosperi, D; Vanna, R; Verderio, P | 1 |
Amirthalingam, M; Jagani, HV; Kasinathan, N; Rao, JV; Reddy, ND; Volety, SM | 1 |
Chen, H; Pang, X; Xi, Y; Yang, C; Zhai, G; Zhao, J | 1 |
Beloqui, A; Coco, R; des Rieux, A; Memvanga, PB; Préat, V; Ucakar, B | 1 |
Kesavan, M; Ramya, K; Sankar, P; Sarkar, SN; Telang, AG; Vijayakaran, K | 1 |
Akbarzadeh, A; Badrzadeh, F; Milani, M; Rahmati-Yamchi, M; Tabatabaei Mirakabad, FS; Taheri-Anganeh, M; Zarghami, N; Zeighamian, V | 1 |
Guo, L; He, G; Huang, W; Li, X; Lin, D; Ouyang, L; Song, X; Wu, F; Zhao, Y | 1 |
Limtrakul, P; Naiki, T; Pitchakarn, P; Punfa, W; Suzuki, S; Takahashi, S; Yodkeeree, S | 1 |
Araújo, PH; Bona, E; Cardozo-Filho, L; Ferro, AC; Gonçalves, OH; Leimann, FV; Silva-Buzanello, RA | 1 |
Hu, X; Huang, F; Liu, Y; Szymusiak, M; Wang, ZJ | 1 |
Dhumale, S; Pandey, SM; Pathak, C; Sharma, A; Waghela, BN | 1 |
Chang, CZ; Kwan, AL; Lin, CL; Wu, SC | 1 |
Biondi, M; Crispi, S; Forte, M; Giarra, S; Mayol, L; Menale, C; Mita, DG; Mita, L; Piccolo, MT; Saija, A; Serri, C | 1 |
Cho, HJ; Choe, JH; Goh, MS; Kang, HJ; Kim, DD; Park, JH; Yoon, IS | 1 |
Fu, Y; Guo, H; Huang, L; Li, Y; Yang, L; Zhang, L | 1 |
Arya, P; Fnu, A; Goel, S; Kundu, B; Mishra, P; Srivastava, A | 1 |
Hathout, RM; Metwally, AA | 1 |
Amirthalingam, M; Kasinathan, N; Rao, JV; Reddy, ND; Vanthi, MB; Volety, SM | 1 |
Al-Jamal, KT; Al-Jamal, WT; Bai, J; Bansal, S; El-Gogary, RI; Klippstein, R; Mustafa, F; Rubio, N; Wang, JT | 1 |
Lei, F; Liu, Z; Si, T; Tong, Q; Xu, RX; Yuan, S | 1 |
Merlin, D; Si, X; Xiao, B; Zhang, M | 1 |
Betbeder, D; Carpentier, R; Howsam, M; Lipka, E | 1 |
Chen, C; Fan, A; Kong, D; Li, H; Li, M; Wang, Z; Zhao, Y | 1 |
Bhardwaj, V; Ganju, L; Nehra, S; Saraswat, D | 1 |
Dai, S; Harada, T; Kee, TW; Leung, MH | 1 |
Han, MK; Merlin, D; Si, X; Viennois, E; Wang, L; Xiao, B; Zhang, M | 1 |
Fan, CD; Fang, J; Fu, XT; Fu, XY; Hou, YJ; Jiang, M; Li, DW; Mao, LL; Sun, BL; Yang, MF; Yin, YX; Zhang, S; Zhang, ZY | 1 |
Ahmed, SH; Elmalahy, MH; Masloub, SM; Mohamed, WS; Sabry, D | 1 |
Hu, X; Huang, F; Liu, Y; Szymusiak, M; Tian, X; Wang, ZJ | 1 |
Chereddy, KK; Préat, V; Vandermeulen, G | 1 |
Chaturvedi, RK; Chopra, D; Dwivedi, A; Gupta, KC; Gupta, SK; Jahan, S; Kushwaha, HN; Pandey, A; Pant, AB; Ray, L; Ray, RS; Singh, J; Singh, KP; Tiwari, SK | 1 |
Chauhan, N; Chauhan, SC; Gara, RK; Jaggi, M; Khan, S; Kumari, S; Maher, DM; Sikander, M; Yallapu, MM; Zafar, N; Zaman, MS | 1 |
Amirthalingam, M; Amuthan, A; Kasinathan, N; Mutalik, S; Nayanabhirama, U; Sreenivasa Reddy, M | 1 |
Chen, D; Fan, KY; Liu, Y; Xia, ZH; Xie, YQ; Yang, F; Yu, AA | 1 |
Harigae, T; Ikeda, I; Inoue, N; Kimura, F; Miyazawa, T; Nakagawa, K | 1 |
Badrzadeh, F; Roointan, A; Sharifi-Rad, J; Sharifi-Rad, M | 1 |
Bhattacharya, MK; Choudhury, MD; Shome, S; Talukdar, AD; Upadhyaya, H | 1 |
Cui, Y; Huang, Y; Jin, H; Xu, Q; Zeng, F; Zhang, M | 1 |
Chen, J; Han, MK; Kang, Y; Merlin, D; Viennois, E; Xiao, B; Zhang, M; Zhang, Z | 1 |
Jia, Y; Liu, S; Liu, X; Pan, W; Tian, C; Wang, H; Wang, Y; Yan, J | 1 |
Argirò, M; Biondi, M; Crispi, S; Forte, M; Giarra, S; Mayol, L; Mita, DG; Mita, L; Piras, L; Saija, A; Serri, C | 1 |
Geneidi, AS; Hathout, RM; Mansour, S; Mehanny, M | 1 |
Aime, S; Alberti, D; Altieri, S; Bortolussi, S; Deagostino, A; Franck, M; Geninatti Crich, S; Protti, N; Stefania, R | 1 |
Akbarzadeh, A; Dariushnejad, H; Pilehvar-Soltanahmadi, Y; Sadeghzadeh, H; Sanjarian, F; Zarghami, N | 1 |
Chen, X; Cun, D; Liu, Z; Sun, L; Tong, HHY; Wang, L; Wang, R; Yan, R; Zheng, Y | 1 |
Grill, AE; Koniar, B; Panyam, J; Shahani, K | 1 |
Kaffashi, A; Mut, M; Oğuz, KK; Orunoğlu, M; Pehlivan, SB; Şahin, S; Söylemezoğlu, F | 1 |
Belletti, D; Forni, F; Luppi, M; Pederzoli, F; Riva, G; Ruozi, B; Tosi, G; Vandelli, MA | 1 |
Gaharwar, US; Kumar, R; Kumar, S; Meena, R; Rajamani, P | 1 |
Akbari Javar, H; Bayrami, S; Dorkoosh, FA; Esmaili, Z; Haddadi-Asl, V; Seyedjafari, E; Zargarian, SS | 1 |
Haggag, YA; Khan, MN; Lane, ME; McCarron, PA; Tambuwala, MM | 1 |
Ma, J; Sun, H; Zhang, B; Zhang, J; Zhou, N | 1 |
Mukerjee, A; Ranjan, AP; Vishwanatha, JK | 1 |
Gdowski, A; Gryczynski, I; Johnson, K; Ranjan, A; Shah, S; Vishwanatha, J | 1 |
Leung, MHM; Shen, AQ | 1 |
Arya, G; Das, M; Sahoo, SK | 1 |
Bisordi, C; Chico, L; Ienco, EC; Lo Gerfo, A; Mancuso, M; Petrozzi, L; Petrucci, A; Siciliano, G | 1 |
Afonso Rabelo Buzalaf, M; Andrade Moreira Machado, MA; Cardoso Oliveira, R; Cruvinel, T; Cusicanqui Méndez, DA; Gutierres, E; José Dionisio, E | 1 |
Gan, SW; Huang, J; Huang, SQ; Jiang, XL; Li, Y; Lu, WT; Qiu, GP; Sun, SQ; Xu, J; Xu, SY; Zhuo, F | 1 |
Gašparović, AČ; Kujundžić, RN; Milković, L; Mojzeš, A; Tomljanović, M; Trošelj, KG | 1 |
Kumar, A; Shukla, D; Soni, VK; Vishvakarma, NK | 1 |
Blontzos, N; Douligeris, A; Fotiou, A; Iavazzo, C; Karavioti, E; Prodromidou, A; Psomiadou, V; Vorgias, G | 1 |
Agabekov, V; Chyshankou, I; Kulikouskaya, V; Pinchuk, S; Vasilevich, I; Volotovski, I | 1 |
Briskey, D; Mallard, AR; Rao, A; Richards BExSSc, A | 1 |
Debata, PR; Pani, S; Patra, A; Sahoo, A | 1 |
Flores, V; Johnston, N; Kheredia, N; Kisiolek, JN; Lisano, J; Ramani, A; Stewart, LK | 1 |
Bahador, A; Pourakbari, B; Pourhajibagher, M | 1 |
Azedi, F; Bayandori, M; Hamblin, MR; Hasanzadeh, A; Heidari, E; Karimi, M; Mohammad Gholinia Sarpoli, L; Zare-Karizi, S | 1 |
Khakbiz, M; Shakibania, S; Zahedi, P | 1 |
Choi, GJ; Choi, YH; Jang, KS; Kim, JC; Kim, JS; Kim, SK; Nguyen, CM; Nguyen, TN | 1 |
Choi, GJ; Choi, YH; Jang, KS; Kim, JC; Nguyen, CM; Nguyen, TN; Park, YJ | 1 |
5 review(s) available for lactic acid and curcumin
Article | Year |
---|---|
Advanced drug delivery systems of curcumin for cancer chemoprevention.
Topics: Animals; Anticarcinogenic Agents; Chemoprevention; Curcumin; Drug Delivery Systems; Emulsions; Humans; Lactic Acid; Liposomes; Mice; Microscopy, Atomic Force; Models, Chemical; Nanoparticles; Neoplasms; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2011 |
Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals.
Topics: Biological Availability; Catechin; Curcumin; Emulsions; Lactic Acid; Liposomes; Micelles; Nanoparticles; Nanotechnology; Phytochemicals; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Quercetin; Resveratrol; Solubility; Stilbenes | 2014 |
Targeting cancer with nano-bullets: curcumin, EGCG, resveratrol and quercetin on flying carpets.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents; Antioxidants; Apoptosis; Catechin; Cell Proliferation; Cell Transformation, Neoplastic; Curcumin; Drug Carriers; Humans; Lactic Acid; Mice; Nanoparticles; Neoplasms; Phytochemicals; Polyglycolic Acid; Polyhydroxyethyl Methacrylate; Polylactic Acid-Polyglycolic Acid Copolymer; Quercetin; Resveratrol; Silicon Dioxide; Stilbenes; Xenograft Model Antitumor Assays | 2014 |
PLGA based drug delivery systems: Promising carriers for wound healing activity.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Curcumin; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Humans; Lactic Acid; Nanoparticles; Neovascularization, Physiologic; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Regenerative Medicine; Wound Healing; Wounds and Injuries | 2016 |
Curcumin as potential therapeutic natural product: a nanobiotechnological perspective.
Topics: Administration, Oral; Animals; Biological Availability; Curcumin; Drug Carriers; Drug Compounding; Humans; Lactic Acid; Lipids; Metal Nanoparticles; Nanotechnology; Oxides; Plant Extracts; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solubility; Technology, Pharmaceutical | 2016 |
3 trial(s) available for lactic acid and curcumin
Article | Year |
---|---|
Amyotrophic Lateral Sclerosis and Oxidative Stress: A Double-Blind Therapeutic Trial After Curcumin Supplementation.
Topics: Advanced Oxidation Protein Products; Aged; Amyotrophic Lateral Sclerosis; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Body Mass Index; Curcumin; Dietary Supplements; Double-Blind Method; Exercise Test; Female; Follow-Up Studies; Hand Strength; Humans; Lactic Acid; Male; Middle Aged; Mutation; Oxidative Stress; Severity of Illness Index; Sulfhydryl Compounds; Superoxide Dismutase-1; Time Factors; Treatment Outcome | 2018 |
Curcumin Improves Delayed Onset Muscle Soreness and Postexercise Lactate Accumulation.
Topics: Adolescent; Adult; Curcumin; Dietary Supplements; Double-Blind Method; Exercise; Humans; Lactic Acid; Male; Muscle, Skeletal; Myalgia; Resistance Training; Young Adult | 2021 |
Short Term, Oral Supplementation with Optimized Curcumin Does Not Impair Performance Improvements Associated with High Intensity Interval Training.
Topics: Athletic Performance; Curcumin; Dietary Supplements; Female; High-Intensity Interval Training; Humans; Lactic Acid; Male; Polyesters | 2022 |
116 other study(ies) available for lactic acid and curcumin
Article | Year |
---|---|
In vitro hemocompatibility studies of drug-loaded poly-(L-lactic acid) fibers.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Blood Vessel Prosthesis; Coated Materials, Biocompatible; Curcumin; Equipment Failure Analysis; Humans; Infusion Pumps, Implantable; Lactic Acid; Materials Testing; Neutrophil Activation; Paclitaxel; Platelet Activation; Platelet Adhesiveness; Polyesters; Polymers; Stents; Surface Properties | 2003 |
Curcumin impregnation improves the mechanical properties and reduces the inflammatory response associated with poly(L-lactic acid) fiber.
Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Biocompatible Materials; Cell Adhesion; Curcumin; Flow Cytometry; Humans; Inflammation; Lactic Acid; Macrophages; Materials Testing; Mice; Microscopy, Electron, Scanning; Neutrophils; Peritoneum; Peroxidase; Phagocytes; Polyesters; Polymers; Superoxides; Surface Properties; Temperature; Tensile Strength; Time Factors | 2005 |
Preparation, characterization and anticoagulation of curcumin-eluting controlled biodegradable coating stents.
Topics: Anticoagulants; Biotransformation; Cell Cycle; Cell Proliferation; Curcumin; Delayed-Action Preparations; Drug Carriers; Drug Compounding; G1 Phase; Lactic Acid; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Partial Thromboplastin Time; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Resting Phase, Cell Cycle; S Phase; Spectroscopy, Fourier Transform Infrared; Stents | 2006 |
In vitro studies of platelet adhesion, activation, and protein adsorption on curcumin-eluting biodegradable stent materials.
Topics: Adsorption; Biocompatible Materials; Coated Materials, Biocompatible; Coronary Restenosis; Coronary Thrombosis; Curcumin; Lactic Acid; Materials Testing; Platelet Activation; Platelet Adhesiveness; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Proteins; Stents | 2007 |
[Comparison of preparing two polylactide nanoparticles loaded lipophilic anti-cancer herb drug by nanoprecipitation method].
Topics: Antineoplastic Agents, Phytogenic; Chemical Precipitation; Cucurbitacins; Curcumin; Drug Compounding; Drugs, Chinese Herbal; Lactic Acid; Nanoparticles; Nanotechnology; Particle Size; Polyesters; Polymers | 2007 |
Improved blood compatibility of rapamycin-eluting stent by incorporating curcumin.
Topics: Absorbable Implants; Adsorption; Angioplasty, Balloon, Coronary; Blood; Coated Materials, Biocompatible; Coronary Restenosis; Curcumin; Fibrinogen; Humans; In Vitro Techniques; Lactic Acid; Materials Testing; Microscopy, Electron, Scanning; Platelet Adhesiveness; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Sirolimus; Spectroscopy, Fourier Transform Infrared; Stents | 2007 |
Development and in vitro evaluation of surface modified poly(lactide-co-glycolide) nanoparticles with chitosan-4-thiobutylamidine.
Topics: Adhesiveness; Animals; Chitin; Curcumin; Delayed-Action Preparations; Drug Carriers; Drug Stability; Hydrogen-Ion Concentration; Intestinal Mucosa; Intestine, Small; Lactic Acid; Mucous Membrane; Nanoparticles; Oxidation-Reduction; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Surface Properties; Swine | 2007 |
[Preparation and anticoagulation of curcumin/poly(lactic acid-co-glycol acid) composite films].
Topics: Coated Materials, Biocompatible; Coronary Restenosis; Curcumin; Drug-Eluting Stents; Humans; Lactic Acid; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers | 2008 |
[Influence of curcumin--loaded poly (lactide-co-glycolide) films on the proliferation of vascular smooth muscle cells].
Topics: Angioplasty, Balloon, Coronary; Animals; Carotid Arteries; Cell Proliferation; Cells, Cultured; Coated Materials, Biocompatible; Coronary Restenosis; Curcumin; Drug-Eluting Stents; Lactic Acid; Muscle, Smooth, Vascular; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats | 2008 |
Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer.
Topics: Alkaloids; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzodioxoles; Biological Availability; Curcumin; Drug Compounding; Electrochemistry; Excipients; Freeze Drying; Intestinal Absorption; Lactic Acid; Male; Microscopy, Atomic Force; Nanoparticles; Particle Size; Piperidines; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polyunsaturated Alkamides; Rats; Rats, Sprague-Dawley; Solubility; Tissue Distribution; X-Ray Diffraction | 2009 |
Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo.
Topics: Animals; Biological Availability; Chemistry, Pharmaceutical; Curcumin; Drug Design; Endocytosis; HCT116 Cells; Humans; Jurkat Cells; Lactic Acid; Mice; Mice, Inbred BALB C; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2010 |
Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy.
Topics: Antineoplastic Agents; Calorimetry, Differential Scanning; Cell Line, Tumor; Cell Survival; Curcumin; Drug Delivery Systems; Humans; Lactic Acid; Male; Microscopy, Confocal; Nanospheres; NF-kappa B; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prostatic Neoplasms | 2009 |
Partial correction of cystic fibrosis defects with PLGA nanoparticles encapsulating curcumin.
Topics: Administration, Oral; Animals; Biological Availability; Biological Transport, Active; Curcumin; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Enzyme Inhibitors; Humans; Lactic Acid; Mice; Mice, Inbred C57BL; Mice, Inbred CFTR; Microscopy, Electron, Scanning; Mutation; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2010 |
Injectable sustained release microparticles of curcumin: a new concept for cancer chemoprevention.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Growth Processes; Cell Line, Tumor; Curcumin; Cyclin D1; Cyclooxygenase 2; Delayed-Action Preparations; Down-Regulation; Female; Humans; Lactic Acid; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Random Allocation; Vascular Endothelial Growth Factor A | 2010 |
Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells.
Topics: Antineoplastic Agents; Cell Proliferation; Curcumin; Drug Carriers; Drug Screening Assays, Antitumor; Humans; Lactic Acid; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Surface Properties; Tumor Cells, Cultured | 2010 |
Swellable hydrogel particles for controlled release pulmonary administration using propellant-driven metered dose inhalers.
Topics: Administration, Inhalation; Aerosol Propellants; Anti-Inflammatory Agents, Non-Steroidal; Chitosan; Curcumin; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Drug Stability; Hydrocarbons, Fluorinated; Hydrogels; Lactic Acid; Lung; Metered Dose Inhalers; Microspheres; Nanoparticles; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2011 |
Curcumin-loaded PLGA-PEG-PLGA triblock copolymeric micelles: Preparation, pharmacokinetics and distribution in vivo.
Topics: Animals; Curcumin; Drug Carriers; Hydrophobic and Hydrophilic Interactions; Kidney; Lactic Acid; Liver; Mice; Micelles; Molecular Structure; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2011 |
Surface functionalization of PLGA nanoparticles by non-covalent insertion of a homo-bifunctional spacer for active targeting in cancer therapy.
Topics: Antibodies; Cell Line, Tumor; Cross-Linking Reagents; Curcumin; Drug Delivery Systems; Humans; Kinetics; Lactic Acid; Microscopy, Confocal; Nanoparticles; Neoplasms; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Spectroscopy, Fourier Transform Infrared; Succinimides; Surface Properties | 2011 |
Highly loaded, sustained-release microparticles of curcumin for chemoprevention.
Topics: Analysis of Variance; Animals; Anticarcinogenic Agents; Biomarkers; Chemistry, Pharmaceutical; Curcumin; Cyclooxygenase 2; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Female; Glutathione Transferase; Injections, Subcutaneous; Kinetics; Lactic Acid; Liver; Mice; Mice, Inbred BALB C; Molecular Weight; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solubility; Solvents; Technology, Pharmaceutical | 2011 |
Sustained targeting of Bcr-Abl + leukemia cells by synergistic action of dual drug loaded nanoparticles and its implication for leukemia therapy.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Curcumin; Drug Synergism; Humans; Lactic Acid; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Membrane Potential, Mitochondrial; Nanoparticles; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymerase Chain Reaction; Sirolimus | 2011 |
Curcumin and its nano-formulation: the kinetics of tissue distribution and blood-brain barrier penetration.
Topics: Animals; Blood-Brain Barrier; Chromatography, High Pressure Liquid; Curcumin; Drug Carriers; Drug Compounding; Lactic Acid; Male; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Surface Properties; Tissue Distribution | 2011 |
Curcumin-loaded into PLGA nanoparticles: preparation and in vitro schistosomicidal activity.
Topics: Animals; Anthelmintics; Curcumin; Drug Carriers; Female; Humans; Lactic Acid; Locomotion; Male; Microscopy, Electron; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Schistosoma mansoni; Survival Analysis | 2012 |
PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms.
Topics: Animals; Biological Availability; Capsules; Curcumin; Drug Carriers; Intestinal Absorption; Lactic Acid; Male; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Solubility | 2011 |
Design of curcumin loaded cellulose nanoparticles for prostate cancer.
Topics: Apoptosis; beta-Cyclodextrins; Cell Line, Tumor; Cell Proliferation; Cellulose; Chemistry, Pharmaceutical; Curcumin; Humans; Lactic Acid; Magnetics; Male; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prostatic Neoplasms; Tumor Stem Cell Assay | 2012 |
In vitro effect on cancer cells: synthesis and preparation of polyurethane membranes for controlled delivery of curcumin.
Topics: 3T3-L1 Cells; Animals; Biocompatible Materials; Cell Line, Tumor; Curcumin; Cyanates; Delayed-Action Preparations; Dimethylpolysiloxanes; Humans; In Vitro Techniques; Kinetics; Lactic Acid; Male; Materials Testing; Membranes, Artificial; Mice; Microscopy, Atomic Force; Permeability; Polyesters; Polymers; Polyurethanes; Rats; Spectroscopy, Fourier Transform Infrared; Steam; Surface Properties; Tensile Strength; Time Factors; X-Ray Diffraction | 2011 |
Interaction of curcumin nanoformulations with human plasma proteins and erythrocytes.
Topics: Analysis of Variance; Blood Proteins; Cell Line, Tumor; Curcumin; Drug Carriers; Erythrocytes; Hemolysis; Humans; Lactic Acid; Male; Materials Testing; Nanogels; Nanostructures; Particle Size; Polyethylene Glycols; Polyethyleneimine; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Protein Binding; Serum Albumin; Spectrophotometry, Ultraviolet | 2011 |
Controlled release pulmonary administration of curcumin using swellable biocompatible microparticles.
Topics: Administration, Inhalation; Aerosols; Animals; Biocompatible Materials; Cell Culture Techniques; Chitosan; Curcumin; Delayed-Action Preparations; Drug Carriers; Hydrogels; Lactic Acid; Lung; Macrophages, Alveolar; Mice; Microspheres; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Powders; Tumor Necrosis Factor-alpha | 2012 |
Tissue localization of nanoparticles is altered due to hypoxia resulting in poor efficacy of curcumin nanoparticles in pulmonary hypertension.
Topics: Administration, Oral; Animals; Curcumin; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Lactic Acid; Lung; Male; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Tissue Distribution | 2012 |
Purely aqueous PLGA nanoparticulate formulations of curcumin exhibit enhanced anticancer activity with dependence on the combination of the carrier.
Topics: Antineoplastic Agents, Phytogenic; Cell Survival; Curcumin; Drug Carriers; HeLa Cells; Humans; Lactic Acid; Microscopy, Electron, Transmission; Nanoparticles; Poly(ADP-ribose) Polymerases; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Transcription Factor RelA | 2012 |
Curcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid; Animals; Antioxidants; Biological Transport; Cell Line, Tumor; Curcumin; Lactic Acid; Mice; Molecular Imaging; Nanoconjugates; Nanoparticles; Peptide Fragments; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Protein Multimerization; Protein Structure, Secondary | 2012 |
Neuronal uptake and neuroprotective effect of curcumin-loaded PLGA nanoparticles on the human SK-N-SH cell line.
Topics: Antioxidants; Cell Line, Tumor; Curcumin; Glutathione; Humans; Lactic Acid; Microscopy, Electron, Transmission; Nanoparticles; Neuroblastoma; Neurons; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Reactive Oxygen Species | 2012 |
Folate decorated dual drug loaded nanoparticle: role of curcumin in enhancing therapeutic potential of nutlin-3a by reversing multidrug resistance.
Topics: Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Curcumin; Drug Carriers; Drug Resistance, Neoplasm; Folic Acid; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Lactic Acid; Membrane Potential, Mitochondrial; Multidrug Resistance-Associated Proteins; Nanoparticles; NF-kappa B; Piperazines; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Proto-Oncogene Proteins c-bcl-2; Retinoblastoma; Tumor Suppressor Protein p53 | 2012 |
Enhancement of cellular uptake and cytotoxicity of curcumin-loaded PLGA nanoparticles by conjugation with anti-P-glycoprotein in drug resistance cancer cells.
Topics: Animals; Antibodies; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Survival; Cervix Uteri; Curcumin; Drug Delivery Systems; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Lactic Acid; Nanoparticles; Particle Size; Poloxamer; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Uterine Cervical Neoplasms | 2012 |
Effects of polymer molecular weight on relative oral bioavailability of curcumin.
Topics: Absorption; Administration, Oral; Animals; Biological Availability; Chromatography, High Pressure Liquid; Curcumin; Intestine, Small; Lactic Acid; Male; Molecular Weight; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats, Sprague-Dawley; Reproducibility of Results; Tissue Distribution | 2012 |
Alendronate coated poly-lactic-co-glycolic acid (PLGA) nanoparticles for active targeting of metastatic breast cancer.
Topics: Alendronate; Animals; Antineoplastic Agents; Bone and Bones; Bone Neoplasms; Boronic Acids; Bortezomib; Breast Neoplasms; Curcumin; Drug Carriers; Female; Humans; Lactic Acid; Mice; Mice, Nude; Nanoparticles; Neoplasm Metastasis; Osteoporosis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrazines | 2012 |
Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapy.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Curcumin; Drug Carriers; Drug Stability; Humans; Lactic Acid; Male; Microscopy, Confocal; Models, Chemical; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Research Design; Transcription Factor RelA | 2012 |
In vitro mutagenicity and blood compatibility of paclitaxel and curcumin in poly (DL-lactide-co-glicolide) films.
Topics: Adsorption; Antineoplastic Agents, Phytogenic; Curcumin; Drug-Eluting Stents; Fibrinogen; Humans; Lactic Acid; Mutagenicity Tests; Mutagens; Paclitaxel; Platelet Activation; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Salmonella typhi; Sirolimus | 2013 |
Intracellular drug release from curcumin-loaded PLGA nanoparticles induces G2/M block in breast cancer cells.
Topics: Apoptosis; Biocompatible Materials; Biological Availability; Breast Neoplasms; Cell Cycle Checkpoints; Cell Proliferation; Curcumin; Cytoplasm; Drug Delivery Systems; Female; Humans; Lactic Acid; MCF-7 Cells; Microscopy, Confocal; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2013 |
Cellular internalization pathway and transcellular transport of pegylated polyester nanoparticles in Caco-2 cells.
Topics: Caco-2 Cells; Curcumin; Humans; Lactic Acid; Membrane Microdomains; Nanoparticles; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Transcytosis | 2013 |
Tumor necrosis factor alpha induces Warburg-like metabolism and is reversed by anti-inflammatory curcumin in breast epithelial cells.
Topics: Anti-Inflammatory Agents; Breast; Cell Line, Tumor; Curcumin; Epithelial Cells; Glucose; Glucose Transporter Type 1; Glycolysis; Humans; Inflammation; Lactic Acid; MCF-7 Cells; Mitochondria; NF-kappa B; Oxygen Consumption; Tumor Microenvironment; Tumor Necrosis Factor-alpha; Walker-Warburg Syndrome | 2013 |
Immunomodulatory effects of nanocurcumin in arsenic-exposed rats.
Topics: Animals; Arsenic; Curcumin; Lactic Acid; Male; Nanoparticles; Nitric Oxide; Nitrites; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Random Allocation; Rats; Rats, Wistar | 2013 |
Combined effect of PLGA and curcumin on wound healing activity.
Topics: Animals; Anti-Inflammatory Agents; Cell Line, Tumor; Cell Survival; Collagen; Curcumin; Female; Glutathione Peroxidase; Keratinocytes; L-Lactate Dehydrogenase; Lactic Acid; Mice; Nanoparticles; NF-kappa B; Peroxidase; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Skin; Tetrazolium Salts; Thiazoles; Wound Healing | 2013 |
Efficacy of biodegradable curcumin nanoparticles in delaying cataract in diabetic rat model.
Topics: Aldehyde Reductase; Animals; Antioxidants; Biocompatible Materials; Biodegradation, Environmental; Blood Glucose; Body Weight; Cataract; Crystallins; Curcumin; Diabetes Mellitus, Experimental; Disease Models, Animal; Disease Progression; Feeding Behavior; Insulin; Lactic Acid; Lens, Crystalline; Malondialdehyde; Nanoparticles; Oxidative Stress; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Protein Carbonylation; Rats; Sorbitol; Streptozocin; Superoxide Dismutase; Treatment Outcome | 2013 |
Orally administered nanocurcumin to attenuate morphine tolerance: comparison between negatively charged PLGA and partially and fully PEGylated nanoparticles.
Topics: Administration, Oral; Animals; Biological Availability; Chemistry, Pharmaceutical; Curcumin; Lactates; Lactic Acid; Male; Mice; Mice, Inbred ICR; Morphine; Nanoparticles; Particle Size; Polyesters; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Suspensions | 2013 |
Protective effect of curcumin on chemotherapy-induced intestinal dysfunction.
Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Behavior, Animal; Biomarkers; Caspase 3; Curcumin; Cytoprotection; D-Amino-Acid Oxidase; Endotoxins; Fluorouracil; Ileum; Intestinal Mucosa; Lactic Acid; Protective Agents; Rats; Rats, Wistar; Time Factors; Weight Loss | 2013 |
Curcumin and 5-fluorouracil-loaded, folate- and transferrin-decorated polymeric magnetic nanoformulation: a synergistic cancer therapeutic approach, accelerated by magnetic hyperthermia.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line; Combined Modality Therapy; Curcumin; Drug Carriers; Fluorouracil; Folic Acid; Humans; Hyperthermia, Induced; Lactic Acid; Magnetite Nanoparticles; MCF-7 Cells; Mice; Nanoconjugates; Nanomedicine; Nanotechnology; Neoplasms; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Transferrin | 2014 |
Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells.
Topics: Adenocarcinoma; Animals; Antigens, Neoplasm; Antineoplastic Agents; Aptamers, Nucleotide; Cell Adhesion Molecules; Cell Survival; Colorectal Neoplasms; Curcumin; Drug Carriers; Drug Delivery Systems; Drug Stability; Epithelial Cell Adhesion Molecule; HEK293 Cells; HT29 Cells; Humans; Lactic Acid; Lecithins; Male; Nanoconjugates; Nanomedicine; Nanoparticles; Nanotechnology; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley | 2014 |
Chemotherapeutic potential of curcumin-bearing microcells against hepatocellular carcinoma in model animals.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biological Availability; Cell Survival; Curcumin; Drug Compounding; Drug Delivery Systems; Female; Hep G2 Cells; Hepatocytes; Humans; Lactic Acid; Liver Neoplasms, Experimental; Mice; Nanomedicine; Nanoparticles; Phytotherapy; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Tumor Necrosis Factor-alpha | 2014 |
Curcumin loaded poly (lactic-co-glycolic) acid nanofiber for the treatment of carcinoma.
Topics: Cell Death; Cell Line, Tumor; Curcumin; Humans; Lactic Acid; Microscopy, Atomic Force; Molecular Weight; Nanofibers; Neoplasms; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Spectroscopy, Fourier Transform Infrared; Viscosity; Water | 2014 |
Preparation and in vitro evaluation of novel poly(anhydride-ester)-based amphiphilic copolymer curcumin-loaded micelles.
Topics: Animals; Cell Cycle; Cell Death; Curcumin; Endocytosis; Esters; HeLa Cells; Hemolysis; Humans; Hydrodynamics; Kinetics; Lactic Acid; Magnetic Resonance Spectroscopy; Micelles; Microscopy, Electron, Transmission; Polyanhydrides; Polyesters; Polyethylene Glycols; Polymers; Rats; Rats, Sprague-Dawley; Spectrometry, Fluorescence; Surface-Active Agents; X-Ray Diffraction | 2014 |
Antiproliferative effect of ASC-J9 delivered by PLGA nanoparticles against estrogen-dependent breast cancer cells.
Topics: 3T3-L1 Cells; Animals; Apoptosis; Biocompatible Materials; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Curcumin; Dose-Response Relationship, Drug; Drug Delivery Systems; Estrogens; Female; Free Radical Scavengers; Humans; Lactic Acid; MCF-7 Cells; Mice; Nanomedicine; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Reactive Oxygen Species; Spectrophotometry, Ultraviolet; Spectrum Analysis, Raman; Time Factors | 2014 |
In-situ implant containing PCL-curcumin nanoparticles developed using design of experiments.
Topics: Animals; Antineoplastic Agents; Curcumin; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Lactic Acid; Mice; Nanoparticles; Particle Size; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solvents; Surface-Active Agents | 2016 |
Development of a folate-modified curcumin loaded micelle delivery system for cancer targeting.
Topics: Animals; Cell Death; Cell Survival; Curcumin; Drug Delivery Systems; Endocytosis; Folic Acid; Hemolysis; Hep G2 Cells; Humans; Irritants; Lactic Acid; Male; MCF-7 Cells; Micelles; Microscopy, Fluorescence; Neoplasms; Particle Size; Polyesters; Polyethylene Glycols; Polymers; Rabbits; Rats; Static Electricity; Surface-Active Agents | 2014 |
pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease.
Topics: Animals; Anti-Inflammatory Agents; Caco-2 Cells; Cell Line; Colitis; Colon; Curcumin; Dextran Sulfate; Disease Models, Animal; Drug Carriers; Female; Humans; Hydrogen-Ion Concentration; Inflammatory Bowel Diseases; Lactic Acid; Macrophages; Mice, Inbred C57BL; Nanoparticles; Neutrophils; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymethacrylic Acids; Tumor Necrosis Factor-alpha | 2014 |
Protective action of curcumin and nano-curcumin against arsenic-induced genotoxicity in rats in vivo.
Topics: Analysis of Variance; Animals; Arsenites; Bone Marrow Cells; Chromosome Aberrations; Comet Assay; Curcumin; DNA Damage; Lactic Acid; Micronuclei, Chromosome-Defective; Molecular Structure; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Sodium Compounds | 2014 |
A Comparison between the cytotoxic effects of pure curcumin and curcumin-loaded PLGA-PEG nanoparticles on the MCF-7 human breast cancer cell line.
Topics: Antineoplastic Agents, Phytogenic; Cell Survival; Curcumin; Drug Carriers; Drug Compounding; Drug Liberation; Female; Humans; Inhibitory Concentration 50; Lactic Acid; MCF-7 Cells; Nanoparticles; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2016 |
Discovery and in vivo evaluation of novel RGD-modified lipid-polymer hybrid nanoparticles for targeted drug delivery.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cholesterol; Curcumin; Drug Carriers; Drug Evaluation, Preclinical; Female; Human Umbilical Vein Endothelial Cells; Humans; Lactic Acid; Lipids; Melanoma; Mice; Mice, Inbred BALB C; Nanoparticles; Oligopeptides; Polyesters; Polyethylene Glycols; Polymers; Transplantation, Homologous | 2014 |
Curcumin-loaded PLGA nanoparticles conjugated with anti- P-glycoprotein antibody to overcome multidrug resistance.
Topics: Animals; Antibodies; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biocompatible Materials; Carcinoma; Cell Line, Tumor; Cell Proliferation; Cell Survival; Curcumin; Drug Delivery Systems; Drug Resistance, Neoplasm; Female; Humans; Lactic Acid; Mice; Mice, Inbred BALB C; Nanoparticles; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Uterine Cervical Neoplasms | 2014 |
Validation of an Ultraviolet-visible (UV-Vis) technique for the quantitative determination of curcumin in poly(L-lactic acid) nanoparticles.
Topics: Curcumin; Lactic Acid; Nanoparticles; Polyesters; Polymers; Spectrophotometry, Ultraviolet | 2015 |
Curcumin attenuates opioid tolerance and dependence by inhibiting Ca2+/calmodulin-dependent protein kinase II α activity.
Topics: Analgesics, Opioid; Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Curcumin; Dose-Response Relationship, Drug; Drug Tolerance; Enzyme Activation; Enzyme Inhibitors; Lactic Acid; Male; Mice; Mice, Inbred ICR; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2015 |
Curcumin conjugated with PLGA potentiates sustainability, anti-proliferative activity and apoptosis in human colon carcinoma cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biological Availability; Biological Transport; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colonic Neoplasms; Curcumin; Delayed-Action Preparations; Humans; JNK Mitogen-Activated Protein Kinases; Lactic Acid; Membrane Potential, Mitochondrial; Mice; NF-kappa B; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Reactive Oxygen Species | 2015 |
Curcumin, encapsulated in nano-sized PLGA, down-regulates nuclear factor κB (p65) and subarachnoid hemorrhage induced early brain injury in a rat model.
Topics: Analysis of Variance; Animals; Biocompatible Materials; Brain Injuries; Caspase 3; Caspase 9; Curcumin; Cytokines; Disease Models, Animal; Down-Regulation; Enzyme Inhibitors; Lactic Acid; Male; Neurologic Examination; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; RNA, Messenger; Subarachnoid Hemorrhage; Transcription Factor RelA | 2015 |
Curcumin loaded PLGA-poloxamer blend nanoparticles induce cell cycle arrest in mesothelioma cells.
Topics: Antineoplastic Agents, Phytogenic; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Chemistry, Pharmaceutical; Curcumin; Drug Carriers; Drug Stability; Drug Tolerance; Humans; Kinetics; Lactic Acid; Mesothelioma; Nanomedicine; Nanoparticles; Particle Size; Poloxamer; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Protein Binding; Solubility; Surface Properties; Technology, Pharmaceutical | 2015 |
Poly(D,L-lactic acid)-glycerol-based nanoparticles for curcumin delivery.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chemistry, Pharmaceutical; Curcumin; Drug Liberation; Glycerol; Lactic Acid; Male; Nanoparticles; Particle Size; Polyesters; Polymers; Rats; Rats, Sprague-Dawley | 2015 |
Preparation and characterization of the ion-fixed mixed micelles with superior stability.
Topics: Antineoplastic Agents; Cell Survival; Curcumin; Drug Compounding; HeLa Cells; Humans; Lactic Acid; Micelles; Nanoparticles; Polyesters; Polyethylene Glycols; Polymers; Pyrenes | 2015 |
Gelsolin Amyloidogenesis Is Effectively Modulated by Curcumin and Emetine Conjugated PLGA Nanoparticles.
Topics: Amino Acid Sequence; Amyloidogenic Proteins; Cell Line; Curcumin; Emetine; Gelsolin; Humans; Hydrophobic and Hydrophilic Interactions; Kinetics; Lactic Acid; Models, Molecular; Molecular Sequence Data; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Protein Aggregation, Pathological; Protein Conformation | 2015 |
Computer-Assisted Drug Formulation Design: Novel Approach in Drug Delivery.
Topics: Antineoplastic Agents; Chemistry, Pharmaceutical; Computer-Aided Design; Curcumin; Drug Carriers; Drug Compounding; Drug Delivery Systems; Humans; Lactic Acid; Lipids; Molecular Dynamics Simulation; Nanoparticles; Neural Networks, Computer; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2015 |
Polycaprolactone-based in situ implant containing curcumin-PLGA nanoparticles prepared using the multivariate technique.
Topics: Animals; Curcumin; Drug Implants; Lactic Acid; Mice; Nanoparticles; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2016 |
Passively Targeted Curcumin-Loaded PEGylated PLGA Nanocapsules for Colon Cancer Therapy In Vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Colonic Neoplasms; Curcumin; Drug Carriers; Drug Delivery Systems; Female; Lactic Acid; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred BALB C; Multimodal Imaging; Nanocapsules; Nanomedicine; Nanoparticles; Neoplasm Transplantation; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Spectroscopy, Fourier Transform Infrared; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2015 |
Coaxial Electrospray of Curcumin-Loaded Microparticles for Sustained Drug Release.
Topics: Cell-Derived Microparticles; Chemistry, Pharmaceutical; Curcumin; Delayed-Action Preparations; Drug Liberation; Lactic Acid; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2015 |
Oral administration of pH-sensitive curcumin-loaded microparticles for ulcerative colitis therapy.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Curcumin; Delayed-Action Preparations; Dextran Sulfate; Drug Carriers; Drug Delivery Systems; Female; Hydrogen-Ion Concentration; Lactic Acid; Mice; Nanoparticles; Organ Size; Particle Size; Peroxidase; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymethacrylic Acids | 2015 |
Evolution of availability of curcumin inside poly-lactic-co-glycolic acid nanoparticles: impact on antioxidant and antinitrosant properties.
Topics: Antioxidants; Cell Line, Tumor; Curcumin; Detergents; Drug Delivery Systems; Endocytosis; Glycolates; Humans; Lactic Acid; Nanoparticles; Nitrogen; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Reactive Oxygen Species; Solubility; Temperature | 2015 |
On-demand combinational delivery of curcumin and doxorubicin via a pH-labile micellar nanocarrier.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Curcumin; Doxorubicin; Drug Carriers; Drug Liberation; Drug Synergism; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Inhibitory Concentration 50; Lactic Acid; Micelles; Microscopy, Confocal; Nanoparticles; Particle Size; Polyesters; Polyethylene Glycols; Polymers; Time Factors | 2015 |
Nanocurcumin Prevents Hypoxia Induced Stress in Primary Human Ventricular Cardiomyocytes by Maintaining Mitochondrial Homeostasis.
Topics: AMP-Activated Protein Kinases; Antioxidants; Cell Hypoxia; Cells, Cultured; Curcumin; Cyclosporine; Glucose; Glucose Transporter Type 1; Glucose Transporter Type 2; Heart Ventricles; Histone Acetyltransferases; Homeostasis; Humans; Lactic Acid; Membrane Potential, Mitochondrial; Mitochondria; Myocytes, Cardiac; Tumor Suppressor Protein p53 | 2015 |
Nanoprecipitation and Spectroscopic Characterization of Curcumin-Encapsulated Polyester Nanoparticles.
Topics: Curcumin; Lactic Acid; Micelles; Nanoparticles; Polyesters; Polymers | 2015 |
Hyaluronic acid-functionalized polymeric nanoparticles for colon cancer-targeted combination chemotherapy.
Topics: Animals; Caco-2 Cells; Camptothecin; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Curcumin; Drug Carriers; Drug Synergism; Humans; Hyaluronic Acid; Immunoglobulin G; Lactic Acid; Male; Melphalan; Mice; Mice, Inbred C57BL; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers | 2015 |
Enhanced Therapeutic Potential of Nano-Curcumin Against Subarachnoid Hemorrhage-Induced Blood-Brain Barrier Disruption Through Inhibition of Inflammatory Response and Oxidative Stress.
Topics: Animals; Blood-Brain Barrier; Curcumin; Dose-Response Relationship, Drug; Inflammation Mediators; Lactic Acid; Male; Mortality; Nanoparticles; Neuroprotective Agents; Oxidative Stress; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Random Allocation; Rats; Rats, Sprague-Dawley; Subarachnoid Hemorrhage | 2017 |
Comparative evaluation of PLGA nanoparticle delivery system for 5-fluorouracil and curcumin on squamous cell carcinoma.
Topics: Apoptosis; Carcinoma, Squamous Cell; Caspase 3; Cell Line, Tumor; Cell Proliferation; Curcumin; Drug Delivery Systems; Drug Screening Assays, Antitumor; Fluorouracil; Head and Neck Neoplasms; Humans; Lactic Acid; Laryngeal Neoplasms; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Squamous Cell Carcinoma of Head and Neck | 2016 |
PLGA-Curcumin Attenuates Opioid-Induced Hyperalgesia and Inhibits Spinal CaMKIIα.
Topics: Analgesics, Opioid; Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Chronic Pain; Curcumin; Drug Delivery Systems; Drug Tolerance; Hyperalgesia; Lactic Acid; Male; Mice; Mice, Inbred ICR; Morphine; Nanostructures; Pain Measurement; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Spinal Cord Dorsal Horn | 2016 |
Photoprotective efficiency of PLGA-curcumin nanoparticles versus curcumin through the involvement of ERK/AKT pathway under ambient UV-R exposure in HaCaT cell line.
Topics: Absorption, Radiation; Animals; Apoptosis; Cell Cycle Checkpoints; Cell Line; Cell Membrane; Cell Survival; Curcumin; Cytoprotection; DNA Breaks; Drug Liberation; Extracellular Signal-Regulated MAP Kinases; Humans; Keratinocytes; Lactic Acid; Membrane Potential, Mitochondrial; Mice; Molecular Docking Simulation; Nanoparticles; NIH 3T3 Cells; Oxidative Stress; Photosensitizing Agents; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Protective Agents; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; RNA, Messenger; Signal Transduction; Ultraviolet Rays | 2016 |
Curcumin Nanoformulation for Cervical Cancer Treatment.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Curcumin; Female; Gene Expression Regulation, Neoplastic; Humans; Lactic Acid; Mice; MicroRNAs; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2016 |
Bioactive PLGA-curcumin microparticle-embedded chitosan scaffold: in vitro and in vivo evaluation.
Topics: Animals; Chitosan; Chlorocebus aethiops; Curcumin; Lactic Acid; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Staphylococcus aureus; Tissue Scaffolds; Vero Cells; Wound Healing | 2017 |
[Relation between drug release and the drug status within curcumin-loaded microsphere].
Topics: Calorimetry, Differential Scanning; Curcumin; Drug Liberation; Lactic Acid; Microscopy, Electron, Scanning; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; X-Ray Diffraction | 2016 |
Metabolic fate of poly-(lactic-co-glycolic acid)-based curcumin nanoparticles following oral administration.
Topics: Administration, Oral; Animals; Biological Availability; Caco-2 Cells; Chromatography, High Pressure Liquid; Curcumin; Humans; Intestinal Mucosa; Lactic Acid; Male; Micelles; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats, Sprague-Dawley; Solubility | 2016 |
A comparison between PLGA-PEG and NIPAAm-MAA nanocarriers in curcumin delivery for hTERT silencing in lung cancer cell line.
Topics: Acrylamides; Cell Line, Tumor; Curcumin; Drug Carriers; Gene Expression; Humans; Lactic Acid; Lung Neoplasms; Microscopy, Electron, Scanning; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymethacrylic Acids; Real-Time Polymerase Chain Reaction; Telomerase | 2016 |
Dual-Targeting Magnetic PLGA Nanoparticles for Codelivery of Paclitaxel and Curcumin for Brain Tumor Therapy.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Curcumin; Drug Delivery Systems; Glioma; Lactic Acid; Mice; Mice, Inbred BALB C; Nanoparticles; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2016 |
Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Biological Products; Cell Line; Colitis, Ulcerative; Colon; Curcumin; Drug Carriers; Drug Therapy, Combination; Epithelial Cells; Fusion Regulatory Protein-1; Hyaluronic Acid; Inflammation; Intestinal Mucosa; Lactic Acid; Macrophages; Male; Mice; Molecular Targeted Therapy; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; RNA, Small Interfering; Treatment Outcome | 2016 |
Co-delivery of docetaxel and curcumin prodrug via dual-targeted nanoparticles with synergistic antitumor activity against prostate cancer.
Topics: Aconitic Acid; Animals; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Coumarins; Curcumin; Docetaxel; Drug Delivery Systems; Drug Liberation; Drug Stability; Drug Synergism; Endocytosis; Humans; Inhibitory Concentration 50; Lactic Acid; Male; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Particle Size; Peptides; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prodrugs; Prostatic Neoplasms; Proton Magnetic Resonance Spectroscopy; Taxoids; Thiazoles | 2017 |
Nano-precipitated curcumin loaded particles: effect of carrier size and drug complexation with (2-hydroxypropyl)-β-cyclodextrin on their biological performances.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; beta-Cyclodextrins; Cell Line, Tumor; Cell Survival; Cells, Cultured; Chemical Precipitation; Curcumin; Drug Carriers; Drug Liberation; Drug Stability; Humans; Lactic Acid; Nanoparticles; Particle Size; Poloxamer; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2017 |
Studying the effect of physically-adsorbed coating polymers on the cytotoxic activity of optimized bisdemethoxycurcumin loaded-PLGA nanoparticles.
Topics: Coated Materials, Biocompatible; Curcumin; Cytotoxins; Diarylheptanoids; Drug Carriers; Hep G2 Cells; Humans; Lactic Acid; Nanoparticles; Neoplasms; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2017 |
Theranostic Nanoparticles Loaded with Imaging Probes and Rubrocurcumin for Combined Cancer Therapy by Folate Receptor Targeting.
Topics: 3T3 Cells; Animals; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Curcumin; Drug Carriers; Female; Folate Receptors, GPI-Anchored; Folic Acid; Gadolinium; Humans; Lactic Acid; Magnetic Resonance Imaging; MCF-7 Cells; Mice; Nanoparticles; Neutron Capture Therapy; Ovarian Neoplasms; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Theranostic Nanomedicine | 2017 |
The Effects of Nanoencapsulated Curcumin-Fe3O4 on Proliferation and hTERT Gene Expression in Lung Cancer Cells.
Topics: Antineoplastic Agents; Cell Proliferation; Cell Survival; Curcumin; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Ferrosoferric Oxide; Humans; Lactic Acid; Lung Neoplasms; Molecular Structure; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Stereoisomerism; Structure-Activity Relationship; Telomerase; Tumor Cells, Cultured | 2017 |
Enhanced topical penetration, system exposure and anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogel.
Topics: Administration, Topical; Animals; Anti-Infective Agents, Local; Apoptosis; Cell Line; Chemistry, Pharmaceutical; Curcumin; Drug Carriers; Drug Liberation; Drug Stability; Female; Humans; Hydrogels; Lactic Acid; Mice, Inbred C57BL; Nanoparticles; Particle Size; Permeability; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Psoriasis; Skin; Skin Absorption; Solubility; Spleen; Surface Properties | 2017 |
Chemopreventive efficacy of curcumin-loaded PLGA microparticles in a transgenic mouse model of HER-2-positive breast cancer.
Topics: Animals; Anticarcinogenic Agents; Breast Neoplasms; Cell Proliferation; Curcumin; Cytokines; Delayed-Action Preparations; Disease Models, Animal; Drug Carriers; Female; Genes, erbB-2; Lactic Acid; Mice, Inbred BALB C; Mice, Transgenic; Neovascularization, Pathologic; NF-kappa B; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Vascular Endothelial Growth Factor A | 2018 |
Effects of curcumin-loaded PLGA nanoparticles on the RG2 rat glioma model.
Topics: Animals; Curcumin; Female; Glioma; Lactic Acid; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar | 2017 |
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Curcumin; Drug Carriers; Drug Liberation; Humans; Lactic Acid; Neoplasms; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Quantum Dots | 2017 |
PLGA-CTAB curcumin nanoparticles: Fabrication, characterization and molecular basis of anticancer activity in triple negative breast cancer cell lines (MDA-MB-231 cells).
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cetrimonium; Cetrimonium Compounds; Curcumin; Cyclin-Dependent Kinase Inhibitor p21; DNA Damage; DNA Repair; Female; Humans; Lactic Acid; Nanoparticles; p38 Mitogen-Activated Protein Kinases; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Reactive Oxygen Species; Triple Negative Breast Neoplasms; Tumor Suppressor Protein p53 | 2017 |
Development and characterization of electrosprayed nanoparticles for encapsulation of Curcumin.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Biocompatible Materials; Buffers; Capsules; Curcumin; Delayed-Action Preparations; Drug Carriers; Electrochemical Techniques; Lactic Acid; Models, Theoretical; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Tissue Engineering | 2018 |
Polymeric Nano-Encapsulation of Curcumin Enhances its Anti-Cancer Activity in Breast (MDA-MB231) and Lung (A549) Cancer Cells Through Reduction in Expression of HIF-1α and Nuclear p65 (Rel A).
Topics: A549 Cells; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Curcumin; Drug Carriers; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lactic Acid; Lung Neoplasms; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Solubility; Transcription Factor RelA | 2018 |
Preparation and Evaluation of Biodegradable Scleral Plug Containing Curcumin in Rabbit Eye.
Topics: Absorbable Implants; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chromatography, High Pressure Liquid; Curcumin; Drug Delivery Systems; Electroretinography; Intravitreal Injections; Lactic Acid; Microscopy, Acoustic; Ophthalmoscopy; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Retina; Sclera; Sclerostomy; Vitreous Body | 2017 |
Targeted Nanocurcumin Therapy Using Annexin A2 Anitbody Improves Tumor Accumulation and Therapeutic Efficacy Against Highly Metastatic Breast Cancer.
Topics: Animals; Annexin A2; Antibodies, Monoclonal; Breast Neoplasms; Cell Line, Tumor; Curcumin; Female; Humans; Lactic Acid; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Theranostic Nanomedicine; Xenograft Model Antitumor Assays | 2016 |
Optimization and scale up of microfluidic nanolipomer production method for preclinical and potential clinical trials.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Curcumin; Drug Carriers; Drug Evaluation, Preclinical; Equipment Design; Humans; Lab-On-A-Chip Devices; Lactic Acid; Liposomes; Male; Mice; Nanoparticles; Phosphatidylethanolamines; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prostatic Neoplasms | 2018 |
Microfluidic Assisted Nanoprecipitation of PLGA Nanoparticles for Curcumin Delivery to Leukemia Jurkat Cells.
Topics: Animals; Curcumin; Drug Delivery Systems; Humans; Jurkat Cells; Lactic Acid; Leukemia; Mice; Microfluidics; Nanoparticles; NIH 3T3 Cells; Particle Size; Polylactic Acid-Polyglycolic Acid Copolymer; Tissue Distribution | 2018 |
Evaluation of curcumin loaded chitosan/PEG blended PLGA nanoparticles for effective treatment of pancreatic cancer.
Topics: Apoptosis; Cell Death; Cell Line, Tumor; Cell Movement; Cell Survival; Chitosan; Curcumin; Endocytosis; Humans; Inhibitory Concentration 50; Lactic Acid; Nanoparticles; Neoplasm Invasiveness; Pancreatic Neoplasms; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Signal Transduction | 2018 |
Curcumin-mediated antimicrobial photodynamic therapy reduces the viability and vitality of infected dentin caries microcosms.
Topics: Animals; Biofilms; Cattle; Curcumin; Dental Caries; Dentin; Dose-Response Relationship, Drug; Lactic Acid; Lactobacillaceae; Microscopy, Confocal; Photochemotherapy; Photosensitizing Agents; Streptococcaceae | 2018 |
Curcumin Ameliorates Memory Deficits by Enhancing Lactate Content and MCT2 Expression in APP/PS1 Transgenic Mouse Model of Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Anti-Inflammatory Agents, Non-Steroidal; Curcumin; Disease Models, Animal; Female; Lactic Acid; Male; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Transgenic; Monocarboxylic Acid Transporters; Presenilin-1 | 2019 |
Cell-Type Specific Metabolic Response of Cancer Cells to Curcumin.
Topics: Cell Line, Tumor; Curcumin; Ethanol; Gene Expression Regulation, Neoplastic; Glucose; Humans; Isoenzymes; Lactic Acid; Neoplasms; Protein Kinases; RNA, Messenger; STAT3 Transcription Factor; Transcription, Genetic | 2020 |
Curcumin circumvent lactate-induced chemoresistance in hepatic cancer cells through modulation of hydroxycarboxylic acid receptor-1.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Survival; Chromatin; Cisplatin; Curcumin; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression Regulation, Neoplastic; Glucose; Hep G2 Cells; Hepatocytes; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lactate Dehydrogenase 5; Lactic Acid; Liver Neoplasms; Monocarboxylic Acid Transporters; Nitric Oxide; Rats; Receptors, G-Protein-Coupled; STAT3 Transcription Factor; Symporters | 2020 |
An Alternative Treatment for Vaginal Cuff Wart: a Case Report.
Topics: Adjuvants, Immunologic; Antineoplastic Agents; beta-Glucans; Colposcopy; Condylomata Acuminata; Curcumin; Drug Combinations; Fatty Alcohols; Female; Humans; Imiquimod; Lactic Acid; Middle Aged; Papanicolaou Test; Papillomavirus Infections; Phyllanthus emblica; Phytotherapy; Plant Preparations; Squamous Intraepithelial Lesions of the Cervix; Vaginal Creams, Foams, and Jellies; Vaginal Diseases; Vaginal Smears | 2020 |
Fabrication and characterization of ultrathin spin-coated poly(L-lactic acid) films suitable for cell attachment and curcumin loading.
Topics: Cell Membrane; Curcumin; Fibroblasts; Humans; Lactic Acid; Materials Testing; Mesenchymal Stem Cells; Polyesters; Polymers; Tissue Engineering; Tissue Scaffolds; Wound Healing | 2020 |
Phytocompounds curcumin, quercetin, indole-3-carbinol, and resveratrol modulate lactate-pyruvate level along with cytotoxic activity in HeLa cervical cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Cell Movement; Cell Proliferation; Cell Survival; Curcumin; Drug Screening Assays, Antitumor; HeLa Cells; Humans; Indoles; Lactic Acid; Pyruvic Acid; Quercetin; Resveratrol; Tumor Cells, Cultured | 2021 |
Contribution of antimicrobial photo-sonodynamic therapy in wound healing: an in vivo effect of curcumin-nisin-based poly (L-lactic acid) nanoparticle on Acinetobacter baumannii biofilms.
Topics: Acinetobacter baumannii; Animals; Anti-Bacterial Agents; Biofilms; Curcumin; Female; Lactic Acid; Mice; Mice, Inbred BALB C; Nanoparticles; Nisin; Photochemotherapy; Ultrasonic Therapy; Wound Healing | 2022 |
Co-delivery of curcumin and Bcl-2 siRNA to enhance therapeutic effect against breast cancer cells using PEI-functionalized PLGA nanoparticles.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Curcumin; Drug Carriers; Emulsions; Female; Glycolates; Humans; Lactic Acid; Nanoparticles; Polyethyleneimine; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; RNA, Small Interfering; Solvents | 2022 |
Investigation and multiscale modeling of PVA/SA coated poly lactic acid scaffold containing curcumin loaded layered double hydroxide nanohybrids.
Topics: Curcumin; Hydroxides; Lactic Acid; Nanofibers; Polyesters; Polyvinyl Alcohol | 2023 |
Production of L- and D-lactic acid from waste Curcuma longa biomass through simultaneous saccharification and cofermentation.
Topics: Biomass; Carbohydrates; Curcuma; Dose-Response Relationship, Drug; Fermentation; Glycine max; Hydrogen-Ion Concentration; Industrial Waste; Lactic Acid; Lactobacillus; Nitrogen; Solvents; Time Factors | 2013 |
Acid hydrolysis of Curcuma longa residue for ethanol and lactic acid fermentation.
Topics: Analysis of Variance; Curcuma; Ethanol; Fermentation; Hydrolysis; Lactic Acid; Sulfuric Acids; Time Factors; Waste Products | 2014 |